capital structure – Piazza Carlo Giuliani http://piazzacarlogiuliani.org/ Mon, 14 Mar 2022 11:00:00 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://piazzacarlogiuliani.org/wp-content/uploads/2021/03/cropped-icon-1-32x32.png capital structure – Piazza Carlo Giuliani http://piazzacarlogiuliani.org/ 32 32 Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and its Proprietary Ultra-High Throughput Screening Platform https://piazzacarlogiuliani.org/ginkgo-bioworks-signs-definitive-agreement-to-acquire-fgen-ag-a-leading-bioengineering-company-and-its-proprietary-ultra-high-throughput-screening-platform/ Mon, 14 Mar 2022 11:00:00 +0000 https://piazzacarlogiuliani.org/ginkgo-bioworks-signs-definitive-agreement-to-acquire-fgen-ag-a-leading-bioengineering-company-and-its-proprietary-ultra-high-throughput-screening-platform/

BOSTON and BASEL, Switzerland, March 14, 2022 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), the leading horizontal cell programming platform, today announced that it has entered into a definitive agreement to acquire FGen AG (“FGen”), a Swiss-based company specializing in the development and optimization of strains. FGen has developed an ultra-high throughput (uHT) screening platform based on nanoliter reactor technology. Ginkgo believes that FGen’s technology will significantly enhance Ginkgo’s cell screening capabilities and allow Ginkgo to explore larger expanses of genetic opportunities, increasing the likelihood of finding enzymes, pathways and strains or cell lines. which operate under various product specifications.

Ginkgo and FGen expect to close the transaction soon. Post-closing, Ginkgo expects that the integration of the FGen platform can significantly increase the capability of Ginkgo’s Design-Build-Test-Learn strain development engine, a foundation of Ginkgo’s technology stack. By adding FGen’s uHT screening platform to its existing HT screening systems, Ginkgo seeks to be able to routinely analyze the performance of millions of genetic prototypes in a pooled format, thereby improving the quality of candidate results that feed downstream workflows for strain characterization and validation. FGen’s platform is extremely flexible for all target organizations, pathways and products. The platform can be deployed to screen for both intracellular and secreted target products as well as small molecules and proteins. It can also host various organisms including bacteria, yeasts, filamentous species and mammalian cells.

“Ginkgo is committed to investing in creating the first cellular programming platform by integrating best-in-class tools from around the world and deploying them widely across our programs,” said Township of Barry, co-founder and chief technology officer of Ginkgo. “We have worked with the FGen team for several years and believe that their world-class technology and scientists will further enhance our ability to explore an exponentially wider design space and deliver more value to our customers.”

“Our team has spent the past decade building one of the world’s most advanced screening platforms in hopes of enabling breakthrough discoveries and products across all industries,” said Andreas Meyer, CEO of FGen. “We are thrilled to be welcomed onto the Ginkgo platform where we can deploy this technology much more widely and better support customers and their world-changing work.”

Under the terms of the transaction, FGen will receive an upfront payment and additional contingent consideration related to, among other things, the successful integration and deployment of FGen technology into Ginkgo programs.

About Ginkgo Bioworks
Ginkgo is building a platform to allow customers to program cells as easily as we can program computers. The Company’s platform enables biotechnology applications in various markets, from food and agriculture to industrial chemicals and pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapy discovery. For more information, visit www.ginkgobioworks.com.

About FGen AG
FGen is a Swiss start-up founded in 2011 in Basel, Switzerland as a spin-off from the Department of Biosystems Science and Engineering at ETH Zurich. As a contract research organization, we collaborate with partners in biotechnology, life sciences, food and pharmaceuticals to develop microbes, cells, chemicals and proteins for various apps. For more information, visit www.fgen.ch.

Ginkgo Bioworks Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of federal securities laws, including statements regarding its expectations regarding the prompt closing of the transaction, the potential success of the acquisition and Ginkgo’s cellular programming platform. These forward-looking statements are generally identified by the words “believe”, “project”, “potential”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future “, “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will,” “will,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, therefore, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from forward-looking statements contained herein, including, but not limited to: (i) the effect of the business combination with Soaring Eagle Acquisition Corp. (“Soaring Eagle”) on Ginkgo’s business, relationships, performance and business in general, (ii) risks whether the business combination disrupts Ginkgo’s current plans and potential difficulties in retaining Ginkgo’s employees, (iii) the outcome of any legal proceedings that may be brought against Ginkgo related to its business combination with Soaring Eagle , (iv) volatility in the price of Ginkgo’s securities now that it is a public company due to various factors, including changes in the competitive and highly regulated industries in which Ginkgo plans to operate, variations in performance between competitors, changes in laws and regulations affecting Ginkgo’s business and changes in the combined capital structure, (v) the ability to implement plans, forecasts and other expectations after completion of the business combination, and identifying and realizing additional opportunities, and (vi) the risk of reduced demand for products using synthetic biology. ic. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of Ginkgo’s Quarterly Report on Form 10-Q filed with the United States Securities and Exchange Commission (the “SEC”). ) the November 15, 2021 and other documents filed by Ginkgo from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to place undue reliance on forward-looking statements, and Ginkgo undertakes no obligation and does not intend to update or revise such forward-looking statements, whether as a result of new information, future events or otherwise. Ginkgo gives no assurance that it will meet its expectations.

GINKGO BIOWORKS INVESTOR CONTACT:
[email protected]ginkgobioworks.com

GINKGO BIOWORKS MEDIA CONTACT:
[email protected]

SOURCE Ginkgo Bioworks

]]>
Series TO1 warrants exercised approximately 75.3% and Veg of Lund receives approximately SEK 6.53 million https://piazzacarlogiuliani.org/series-to1-warrants-exercised-approximately-75-3-and-veg-of-lund-receives-approximately-sek-6-53-million/ Sat, 12 Mar 2022 08:11:03 +0000 https://piazzacarlogiuliani.org/series-to1-warrants-exercised-approximately-75-3-and-veg-of-lund-receives-approximately-sek-6-53-million/

Today, Veg from Lund AB (pub) (“Vegetable of lund” or the “Company”) announces the result of the exercise of the series TO1 warrants (the “Warrants”), which were issued during the third quarter of 2021. In total, 590,865 subscription were exercised, corresponding to approximately 75.3% of the total number of Warrants in circulation, for the subscription of 590,865 shares at a subscription price of SEK11.06 per new share. Lund Vegetablesthus receives approximately 6.53 million Swedish crowns before issuing fees by exercising the Warrants.

“It’s gratifying that so many people have chosen to participate in the financing of Lund Vegetables and our continued launch of DUG®. The main shareholders and members of the Board of Directors have exercised their warrants and thus show their continued support in the important phase that the company is going through. We can now focus on increasing market share, mainly in the UK and Sweden while the board continues to actively evaluate various financing options to ensure the company’s long-term funding and optimal capital structure based on the ongoing launch,” said Emma Källqvist, interim CEO. and Chief Financial Officer of Lund Vegetables.

Context:

The exercise period of the Warrants took place from February 25, 2022 up to and including March 10, 2022. The subscription price per share subscribed by exercise of the BSAs was set at SEK11.06 as communicated by press release on February 24, 2022.

A total of 590,865 warrants were exercised to subscribe for 590,865 shares, which means that approximately 75.3% of all outstanding warrants were exercised to subscribe for shares.

The warrants exercised have been replaced by interim shares (IA), pending registration with the Swedish Companies Registration Office. The provisional shares should be converted into shares within approximately three (3) weeks.

Number of shares, share capital and dilution:

Through the exercise of the Warrants, the number of shares in Lund Vegetables increases by 590,865 shares, from 12,224,336 shares to 12,815,201 shares. The share capital increases with SEK37,815.360 from SEK 782,357.504 for SEK 820,172,864.

For existing shareholders who have not exercised any Warrants, the dilution amounts to approximately 4.6% based on the number of shares after the exercise of the Warrants.

Advisors

Mangold Fondkommission AB is the financial advisor and issuing agent and Fredersen Advokatbyrå is the legal advisor to Lund Vegetables within the framework of the exercise of the Warrants.

For more information regarding the Warrants, please contact:

Mangold Fondkommission AB
Telephone: +46 8 5050 1595
E-mail: transmitter@mangold.se

For more information please contact:

Veg from Lund AB
Emma Källqvist (acting CEO and CFO)
Telephone: +46 721 869 018
E-mail: emma.kallqvist@vegoflund.se

This information is such as Lund Vegetables is required to make public in accordance with the EU Market Abuse Regulation. The information has been submitted for publication, through the above contact person, the March 12, 2022 at 09:10 CET.

On Veg from Lund AB (pub)
Lund Vegetables develops unique plant foods that meet consumer demands for taste and sustainability. The company has roots in research at Lund University and has patented methods for developing new food categories in the growing plant-based food market. Lund Vegetables climate-smart and tasty products are sold in Europe and Asia under the DUG® Mark. The company’s stock is listed on the Nasdaq First North Growth Market under the symbol VOLAB. Learn more at ir.vegoflund.se. Mangold Fondkommission AB is the company’s certified advisor and can be contacted by telephone: +46 8 5030 15 50 or by e-mail: ca@mangold.se.

https://news.cision.com/veg-of-lund/r/warrants-of-series-to1-were-exercised-to-approximately-75-3-percent-and-veg-of-lund-receives- c3523755

https://mb.cision.com/Main/18795/3523755/1547521.pdf

(c) Decision 2022. All rights reserved., sources Press Releases – English

]]>
EOH eyes UK and EU markets for growth opportunities https://piazzacarlogiuliani.org/eoh-eyes-uk-and-eu-markets-for-growth-opportunities/ Tue, 08 Mar 2022 06:51:08 +0000 https://piazzacarlogiuliani.org/eoh-eyes-uk-and-eu-markets-for-growth-opportunities/ EOH is looking for growth opportunities outside of the country. EOH says it is well placed to expand into new markets, with sub-Saharan Africa, the UK and the EU as targets. The technology group sold non-core assets to free up cash to reduce debt. Data analytics, …]]> growth opportunities outside of the country.” height=”351″ width=”625″ class=”img-lazy”/>

EOH is looking for growth opportunities outside of the country.

  • EOH says it is well placed to expand into new markets, with sub-Saharan Africa, the UK and the EU as targets.
  • The technology group sold non-core assets to free up cash to reduce debt.
  • Data analytics, cybersecurity and cloud consulting to new customers are seen as another growth area.

Technology group EOH – which embarked on a recovery strategy following the outbreak of a corruption scandal involving senior executives – plans to expand into new markets as part of its growth strategy.

The company is in the process of engaging investors to define its strategic options and is seeking South African companies with a UK or EU presence for potential growth opportunities. Increasing sales of software development, data analytics, cybersecurity, clean IP products and cloud consulting to new customers are seen as another growth area.

“EOH is at the point where it needs a right-sized capital structure to prepare the business for the resumption of a growth-oriented strategy driven by cross-selling opportunities,” the company said.

The company sees itself as well positioned to expand into new markets and customers through a profitable service offering, focused in sub-Saharan Africa, Egypt and the UK.

Part of its turnaround involved debt reduction, which led it to sell some of its assets. The company’s debt stood at just over R4.5 billion in the 2018 financial year, which it said was the result of an “aggressive acquisition growth phase”.

Debt has been reduced to around R2 billion, with R1.4 billion repaid.

Its high debt levels have been compounded by a “complicated structure” with 272 legal entities and duplicate management, sales structures and real estate leasing inefficiencies. It posted a loss of R1.3 billion in 2020 and turned profitable in the full 2021 financial year.

An amount of R750 million is expected from the disposal of non-core assets.

“Resizing the capital structure will allow EOH to pursue a growth strategy, immediately improve earnings and ultimately create shareholder value.”

EOH’s reputation took a hit in 2019 when an ENSafrica investigation uncovered a web of bribery, bribery and overpayment of corporate development providers in a circle involving its senior executives. Most of the questionable transactions involved the firm’s subsidiary, EOH Mthombo, which had major contracts with the public sector.

]]>
Should you investigate RBG Holdings plc (LON:RBGP) at £1.02 in the UK? https://piazzacarlogiuliani.org/should-you-investigate-rbg-holdings-plc-lonrbgp-at-1-02-in-the-uk/ Sat, 05 Mar 2022 08:33:21 +0000 https://piazzacarlogiuliani.org/should-you-investigate-rbg-holdings-plc-lonrbgp-at-1-02-in-the-uk/

While RBG Holdings plc (LON:RBGP) may not be the best-known stock right now, it has seen significant price moves over the past few months on AIM, reaching highs from UK£1.37 and falling to lows of UK£1.02. . Certain movements in the stock price can give investors a better opportunity to get into the stock and potentially buy at a lower price. A question that needs to be answered is whether RBG Holdings’ current trading price of UK£1.02 reflects the true value of the small cap? Or is it currently undervalued, giving us the opportunity to buy? Let’s take a look at the outlook and value of RBG Holdings based on the most recent financial data to see if there are any catalysts for a price change.

Check out our latest analysis for RBG Holdings

What is the opportunity at RBG Holdings?

Good news for investors – RBG Holdings is still trading at a fairly cheap price according to my multiple price model, where I compare the company’s price-earnings ratio to the industry average. In this case, I used the Price/Earnings (PE) ratio since there is not enough information to reliably predict the stock’s cash flow. I find RBG Holdings’ ratio of 11.67x to be below its average of 25.46x, indicating that the stock is trading at a lower price than the professional services sector. However, there may be another chance to buy again in the future. This is because RBG Holdings’ beta (a measure of stock price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s stock will likely fall more than the rest of the market, providing an excellent buying opportunity.

What does the future of RBG Holdings look like?

TARGET: RBGP Earnings and Revenue Growth March 5, 2022

Future prospects are an important aspect when considering buying a stock, especially if you are an investor looking to grow your portfolio. Buying a big company with solid prospects at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. With revenues expected to grow 38% over the next year, the future looks bright for RBG Holdings. If the level of spending can be maintained, it looks like higher cash flow is expected for the stock over the coming year, which should translate into a higher valuation for the stock.

What does this mean to you :

Are you a shareholder? Given that RBGP is currently trading below the industry PE ratio, now may be the perfect time to build up more of your holdings in the stock. With an optimistic outlook on the horizon, it appears that this growth has yet to be fully priced into the stock price. However, there are also other factors such as the capital structure to consider, which could explain the current price multiple.

Are you a potential investor? If you’ve been watching RBGP for a while, it might be time to get into the stock. Its prosperous future prospects are yet to be fully reflected in the current share price, meaning it’s not too late to buy RBGP. But before making investment decisions, consider other factors such as the track record of its management team, in order to make an informed assessment.

So while earnings quality is important, it is equally important to consider the risks that RBG Holdings currently faces. For example, we found 3 warning signs which you should browse to get a better picture of RBG Holdings.

If you are no longer interested in RBG Holdings, you can use our free platform to view our list of over 50 other stocks with high growth potential.

This Simply Wall St article is general in nature. We provide commentary based on historical data and analyst forecasts only using unbiased methodology and our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or financial situation. Our goal is to bring you targeted long-term analysis based on fundamental data. Note that our analysis may not take into account the latest announcements from price-sensitive companies or qualitative materials. Simply Wall St has no position in the stocks mentioned.

]]>
Venture Capital Firm Sequoia Capital Bets Big on Crypto https://piazzacarlogiuliani.org/venture-capital-firm-sequoia-capital-bets-big-on-crypto/ Sun, 20 Feb 2022 16:42:15 +0000 https://piazzacarlogiuliani.org/venture-capital-firm-sequoia-capital-bets-big-on-crypto/

Cryptocurrencies might be posting losses for their investors right now, but there is enough money flowing into this space despite the volatile nature of this asset.

Experts believe the growth of crypto is here to stay.

Leading California venture capital firm Sequoia is the latest to pledge nearly $600 million to become a more active investor in crypto.

The timing of the investment is perhaps a crucial reminder that despite a bitcoin crisis, the cryptocurrency is seen as a bullish asset.

Right now, bitcoin has once again fallen to the $40,000 mark, a first in the past two weeks. Bitcoin is trading near $39,891 at the time of writing according to CoinGecko, a price tracking website for crypto assets.